Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E isoprotein-specific interactions with tissue plasminogen activator.

Susan J Biehle1, Janice Carrozzella, Rakesh Shukla

  • 1Department of Neurology, University of Cincinnati Medical Center, ML 0536, OH 45267-0536, USA. Susan.Biehle@uc.edu

Biochimica Et Biophysica Acta
|July 28, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elucidating the Limited Solubility of Y<sup>3+</sup> in La<sub>2</sub>Ti<sub>2</sub>O<sub>7</sub>: Looking Beyond Radius Ratio Guidelines.

Inorganic chemistry·2026
Same author

Using radiological brain health to predict recurrence after ischemic stroke and transient ischemic attack: A population-based study.

Neurology open access·2026
Same author

Antibody format matters: A comparative analysis of VHH and scFv domains reveals superior in vivo CAR T cell function with VHH domains.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Tailorable Electrical Materials by Simultaneous Maneuvering of <i>A</i>-Sites and <i>B</i>-Sites in BaTiO<sub>3</sub>.

Inorganic chemistry·2026
Same author

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

High-Pressure Structural Evolution of Na<sub>2</sub>ZrSi<sub>2</sub>O<sub>7</sub> and Na<sub>2</sub>ZrSi<sub>2</sub>O<sub>7</sub>·H<sub>2</sub>O: Topology-Driven Compression Behaviors, Phase Stability, and Electronic Transitions.

Inorganic chemistry·2025

Apolipoprotein E (Apo E) isoprotein-specific interactions with tissue plasminogen activator (tPA) were investigated. Apo E2, but not E3 or E4, showed significant conformational changes upon interaction with tPA, impacting biological processes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Apolipoprotein E (Apo E) is a key genetic risk factor for neurological, vascular, and cardiovascular diseases.
  • Previous studies indicated Apo E isoprotein-specific modulation of tissue plasminogen activator (tPA) in vitro.

Purpose of the Study:

  • To investigate the conformational changes of Apo E isoforms (E2, E3, E4) when interacting with tPA.
  • To determine if tPA induces conformational changes in Apo E isoforms.

Main Methods:

  • Circular dichroism (CD) spectroscopy to analyze protein structure.
  • Dual polarization interferometry (DPI) to study molecular interactions.
  • In vitro assays using immobilized tPA and lipidated Apo E isoforms.

Related Experiment Videos

Main Results:

  • Apo E2 exhibited significant, isoprotein-specific conformational changes upon interaction with immobilized tPA, unlike Apo E3 and E4.
  • Tissue plasminogen activator (tPA) induced changes in the helicity of lipidated Apo E2.
  • No detectable conformational changes were observed for Apo E3 or E4 in the presence of tPA.
  • Statistical analysis (Tukey's test) confirmed a significant interaction (P < 0.001) between tPA and lipidated Apo E2.

Conclusions:

  • The findings reveal isoprotein- and state-specific intermolecular interactions between Apo E isoforms and tPA.
  • These interactions, particularly with Apo E2, may elucidate the mechanisms behind Apo E's role in diseases involving blood clotting, proteolysis, and perfusion.